News

Genentech, a member of the Roche group announced that new data from three Phase III studies of the investigational medicine OCREVUS™ (ocrelizumab) will be presented during the 68th American Academy of Neurology (AAN) annual meeting from April 15-21...

Sanofi announced a €300 million investment to expand its site in Geel, Belgium. The investment furthers Sanofi’s commitment to driving the future of biologics by expanding manufacturing and commercial capabilities in order to ensure quality, capacity, and scale. ...

Baxter International Inc  will present at the 2016 Bank of America Healthcare Conference on Tuesday, May 10, 2016 in Las Vegas, Nevada. Joe Almeida, chairman and chief executive officer, is scheduled to present at 7:00 p.m. (CDT). ...

Roche announced that the U.S. FDA granted accelerated approval to Venclexta™ (venetoclax) for the treatment of people with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior...

Experimental “Internet of Things” System Uses Connected Devices to Enable Remote Measurement of Health and Quality of Life in Real-Time.Multi-Year Project Could Potentially Change How Clinical Trials are Conducted. Pfizer Inc and IBM announced a first-of-its-kind...

Sandoz, a Novartis division and the global leader in biosimilars, announced that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.) route of administration in Binocrit's® (epoetin alfa) nephrology indication. ...

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Valganciclovir Tablets USP, 450 mg. This product is to be launched in Q1...